Pascal Delépine

785 total citations
26 papers, 627 citations indexed

About

Pascal Delépine is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pascal Delépine has authored 26 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Genetics and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pascal Delépine's work include RNA Interference and Gene Delivery (16 papers), Virus-based gene therapy research (9 papers) and Advanced biosensing and bioanalysis techniques (9 papers). Pascal Delépine is often cited by papers focused on RNA Interference and Gene Delivery (16 papers), Virus-based gene therapy research (9 papers) and Advanced biosensing and bioanalysis techniques (9 papers). Pascal Delépine collaborates with scholars based in France, Switzerland and Italy. Pascal Delépine's co-authors include Tristan Montier, Claude Férec, Jean‐Jacques Yaouanc, Tony Le Gall, Dominique Cartier, Pierre Lehn, C. Guillaume, Jean‐Claude Clément, Philippe Giamarchi and F. Lamarche and has published in prestigious journals such as Chemical Communications, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Pascal Delépine

25 papers receiving 608 citations

Peers

Countries citing papers authored by Pascal Delépine

Since Specialization

Citations

This map shows the geographic impact of Pascal Delépine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Delépine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Delépine more than expected).

Fields of papers citing papers by Pascal Delépine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Delépine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Delépine. The network helps show where Pascal Delépine may publish in the future.

Co-authorship network of co-authors of Pascal Delépine

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Delépine. A scholar is included among the top collaborators of Pascal Delépine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Delépine. Pascal Delépine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adhesion, proliferation and osteogenic differentiation of human MSCs cultured under perfusion with a marine oxygen carrier on an allogenic bone substitute 2017 ·Artificial Cells Nanomedicine and Biotechnology ·(unknown), Gaëlle Richard, (unknown), Sophie Sourice, F. Dubrana, Claude Férec, (unknown), R. Pace, Pierre Weiss, Franck Zal, Pascal Delépine, (unknown)	19
2	Advancement in recombinant protein production using a marine oxygen carrier to enhance oxygen transfer in a CHO-S cell line 2015 ·Artificial Cells Nanomedicine and Biotechnology ·(unknown), (unknown), Delphine Dutheil, M Rousselot, (unknown), Claude Férec, (unknown), Pascal Delépine, Franck Zal	13
3	Biosimilars of filgrastim in autologous stem cell transplant: reduction in granulocyte-colony stimulating factor costs, but similar effects on bone marrow recovery 2013 ·Leukemia & lymphoma ·Jean‐Christophe Ianotto, (unknown), (unknown), Adrian Tempescul, Nathalie Mugnier, Pascal Delépine, Gaëlle Guillerm, Christian Berthou	10
4	Delayed G‐CSF stimulation after PBSCT does not seem to modify the biological parameters of bone marrow recovery 2011 ·American Journal of Hematology ·Jean‐Christophe Ianotto, Adrian Tempescul, Pascal Delépine, Gaëlle Guillerm, Elisabeth Hardy, (unknown), Christian Berthou	2
5	A Novel Cationic Lipophosphoramide with Diunsaturated Lipid Chains: Synthesis, Physicochemical Properties, and Transfection Activities 2010 ·Journal of Medicinal Chemistry ·Tony Le Gall, D. Loizeau, (unknown), Nathalie Carmoy, Jean‐Jacques Yaouanc, (unknown), Pascal Delépine, Philippe Giamarchi, Paul‐Alain Jaffrès, Pierre Lehn, Tristan Montier	67
6	New Phosphoramidate Dicationic Vectors for Gene Therapy 2008 ·Phosphorus, sulfur, and silicon and the related elements ·Mathieu Mével, F. Lamarche, Jean‐Claude Clément, Jean‐Jacques Yaouanc, Pascale Laurent, (unknown), Philippe Giamarchi, Tristan Montier, Pascal Delépine, Pierre Lehn, Paul‐Alain Jaffrès, Claude Férec	1
7	Archaeosomes based on synthetic tetraether-like lipids as novel versatile gene delivery systems 2007 ·Chemical Communications ·(unknown), Tristan Montier, Tony Le Gall, Pascal Delépine, Sandrine Cammas‐Marion, Loı̈c Lemiègre, P Lehn, Thierry Benvegnu	63
8	Lipophosphoramidates as Lipidic Part of Lipospermines for Gene Delivery 2007 ·Bioconjugate Chemistry ·F. Lamarche, Mathieu Mével, Tristan Montier, (unknown), Philippe Giamarchi, Raphaël Tripier, Pascal Delépine, Tony Le Gall, Dominique Cartier, Pierre Lehn, Paul‐Alain Jaffrès, Jean‐Claude Clément	35
9	EPI-hNE4, a Proteolysis-Resistant Inhibitor of Human Neutrophil Elastase and Potential Anti-Inflammatory Drug for Treating Cystic Fibrosis 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Sylvie Attucci, (unknown), Brice Korkmaz, Pascal Delépine, (unknown), (unknown), P. Diot, Francis Gauthier	43
10	Cationic Lipophosphoramidates and Lipophosphoguanidines Are Very Efficient for in Vivo DNA Delivery 2005 ·Bioconjugate Chemistry ·(unknown), (unknown), Pascal Delépine, (unknown), Jean‐Jacques Yaouanc, Dominique Cartier, (unknown), Claude Férec, (unknown)	56
11	KLN-5: a safe monocationic lipophosphoramide to transfect efficiently haematopoietic cell lines and human CD34+ cells 2004 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Tristan Montier, Pascal Delépine, (unknown), Yann Fichou, (unknown), Eugenio Hardy, (unknown), Jean‐Christophe Clément, Jean‐Jacques Yaouanc, Claude Férec	17
12	CFTR Transgene Expression in Primary ΔF508 Epithelial Cell Cultures From Human Nasal Polyps Following Gene Transfer With Cationic Phosphonolipids 2004 ·Molecular Biotechnology ·Tristan Montier, Pascal Delépine, R. Marianowski, (unknown), (unknown), (unknown), G. Potard, (unknown), I. Frachon, (unknown), Jean‐Claude Clément, (unknown), Claude Férec	11
13	Characteristics of EPI-hNE4 Aerosol: A New Elastase Inhibitor for Treatment of Cystic Fibrosis 2003 ·Journal of Aerosol Medicine ·Daniel Grimbert, Laurent Vecellio, Pascal Delépine, Sylvie Attucci, E Boissinot, (unknown), Francis Gauthier, C Valat, (unknown), (unknown), P. Diot	21
14	The use of in situ hybridization to study the transgene pathway following cellular transfection with cationic phosphonolipids 2003 ·Blood Cells Molecules and Diseases ·Tristan Montier, Annie Cavalier, Pascal Delépine, Christine Guillaume, (unknown), (unknown), (unknown), Daniel Thomas, Claude Férec	8
15	Biodistribution study of phosphonolipids: a class of non‐viral vectors efficient in mice lung‐directed gene transfer 2003 ·The Journal of Gene Medicine ·Pascal Delépine, C. Guillaume, Tristan Montier, Jean‐Christophe Clément, Jean‐Jacques Yaouanc, H. DES ABBAYES, F. Berthou, A. Le Pape, Claude Férec	20
16	Visualization of the transgene distribution according to the administration route allows prediction of the transfection efficacy and validation of the results obtained 2002 ·Gene Therapy ·Pascal Delépine, Tristan Montier, C. Guillaume, Laurence Vaysse, A. Le Pape, Claude Férec	14
17	Aerosolization of Cationic Lipid–DNA Complexes: Lipoplex Characterization and Optimization of Aerosol Delivery Conditions 2001 ·Biochemical and Biophysical Research Communications ·Christine Guillaume, Pascal Delépine, (unknown), Tristan Montier, G. Tymen, Claude Férec	14
18	Systemic administration of cationic phosphonolipids/DNA complexes and the relationship between formulation and lung transfection efficiency 2000 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Virginie Floch, Pascal Delépine, C. Guillaume, Séverine Loisel, Scott Chasse, (unknown), (unknown), J.P. Leroy, Claude Férec	31
19	Cationic Phosphonolipids as Nonviral Vectors: In Vitro and in Vivo Applications 2000 ·Journal of Pharmaceutical Sciences ·Pascal Delépine, C. Guillaume, Virginie Floch, Séverine Loisel, Jean‐Jacques Yaouanc, Jean‐Christophe Clément, H. DES ABBAYES, Claude Férec	26
20	Phosphonocationic Lipids in Protein Delivery to Mice Lungs 2000 ·Journal of Pharmaceutical Sciences ·Christine Guillaume, Pascal Delépine, Bernard Mercier, Eric Gobin, Jean‐Paul Leroy, Vincent Morin, Claude Férec	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact